Cargando…
High-Throughput Antibody Profiling Identifies Targets of Protective Immunity against P. falciparum Malaria in Thailand
Malaria poses a significant global health challenge, resulting in approximately 600,000 deaths each year. Individuals living in regions with endemic malaria have the potential to develop partial immunity, thanks in part to the presence of anti-plasmodium antibodies. As efforts are made to optimize a...
Autores principales: | Hassan, Ifra, Kanoi, Bernard N., Nagaoka, Hikaru, Sattabongkot, Jetsumon, Udomsangpetch, Rachanee, Tsuboi, Takafumi, Takashima, Eizo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452476/ https://www.ncbi.nlm.nih.gov/pubmed/37627332 http://dx.doi.org/10.3390/biom13081267 |
Ejemplares similares
-
PfMSA180 is a novel Plasmodium falciparum vaccine antigen that interacts with human erythrocyte integrin associated protein (CD47)
por: Nagaoka, Hikaru, et al.
Publicado: (2019) -
Meta-Analysis of Human Antibodies Against Plasmodium falciparum Variable Surface and Merozoite Stage Antigens
por: Takashima, Eizo, et al.
Publicado: (2022) -
Natural infection of Plasmodium falciparum induces inhibitory antibodies to gametocyte development in human hosts
por: Tonwong, Natda, et al.
Publicado: (2010) -
Identification of Novel Malaria Transmission-Blocking Vaccine Candidates
por: Takashima, Eizo, et al.
Publicado: (2021) -
Antibodies against a short region of PfRipr inhibit Plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A
por: Nagaoka, Hikaru, et al.
Publicado: (2020)